One of PHA Europe’s missions is to ensure that EU-level policies and initiatives take better account of pulmonary hypertension and rare diseases as well as those affected by them. PHA Europe’s advocacy program aims to raise awareness of these issues with the three main EU institutions – The European Commission, Council of MInisters and European Parliament.
Advocacy activity at EU level – 2012 onwards
Last updated: August 25, 2015
Find a local specialist
Select a country